9/17/2024 1:10:02 PM - Reported Jun '24 quarterly earnings +34% on +10% sales revenues versus the year ago period. Prior quarterly comparison were not strong and steady above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history had a downturn in FY '22.

7/23/2024 1:42:30 PM - Reported Jun '24 quarterly earnings +34% on +10% sales revenues versus the year ago period. Prior quarterly comparison were not strong and steady above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history had a downturn in FY '22.

3/31/2022 1:04:39 PM - Priced a new Public Offering on 9/16/21 then made progress into new 52-week high territory, and now consolidating near its 50 DMA line. Reported Dec '21 quarterly earnings +22% on +40% sales revenues versus the year ago period. Prior quarterly comparison were not strong and steady above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

1/21/2022 12:43:03 PM - Priced a new Public Offering on 9/16/21 then made progress into new 52-week high territory, and now retesting its 50 DMA line. Last noted with caution in the 11/12/21 mid-day report - "Reported Sep '21 quarterly earnings +39% on +29% sales revenues versus the year ago period. Prior quarterly comparison was below the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017."

11/12/2021 1:02:31 PM - Priced a new Public Offering on 9/16/21 and it is hovering near its 52-week high after an impressive streak of gains. Found support above its 50 DMA line ($87.14). Reported Sep '21 quarterly earnings +39% on +29% sales revenues versus the year ago period. Prior quarterly comparison was below the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

10/21/2021 1:10:35 PM - Priced a new Public Offering on 9/16/21 and it is hitting yet another new 52-week high with today's volume-driven gain. Found support above its 50 DMA line ($81). Reported Sep '21 quarterly earnings +39% on +29% sales revenues versus the year ago period. Prior quarterly comparison was below the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/27/2021 1:16:21 PM - Priced a new Public Offering on 9/16/21 and it is hitting another new 52-week high with today's volume-driven gain. Found support above its 50 DMA line ($74.91). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 4 prior quarterly comparisons had earnings growth above the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/24/2021 12:17:04 PM - Priced a new Public Offering on 9/16/21 and it is hitting a new 52-week high with today's 3rd consecutive gain. Found support above its 50 DMA line ($74.46). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 4 prior quarterly comparisons had earnings growth above the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/23/2021 12:13:46 PM - Priced a new Public Offering on 9/16/21 and it is challenging its 52-week high with today's gain. Found support above its 50 DMA line ($74). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 4 prior quarterly comparisons had earnings growth above the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/17/2021 1:04:37 PM - Priced a new Public Offering and powered to a new 52-week high on the prior session. Found support above its 50 DMA line ($72.54). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 4 prior quarterly comparisons had earnings growth above the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/16/2021 12:33:10 PM - Priced a new Public Offering and it is powering to a new 52-week high. Found support above its 50 DMA line ($72.15). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 4 prior quarterly comparisons had earnings growth above the +25% minimum guideline (C criteria). Prior quarters also showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

9/14/2021 12:47:43 PM - Pulling back from its 52-week high and toward its 50 DMA line ($71.38). Reported Jun '21 quarterly earnings +21% on +18% sales revenues versus the year ago period. The 5 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria). Prior quarters showed sub par sales revenues growth leaving fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

7/8/2021 12:34:55 PM - Slumped from near its 52-week high and below its 50 DMA line ($62.87). Reported Mar '21 quarterly earnings +47% on +6% sales revenues versus the year ago period. The 4 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

7/7/2021 12:47:51 PM - Slumped from near its 52-week high and below its 50 DMA line ($62.94). Reported Mar '21 quarterly earnings +47% on +6% sales revenues versus the year ago period. The 4 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

4/23/2021 12:42:41 PM - Reported Mar '21 quarterly earnings +47% on +6% sales revenues. Hitting new 52-week highs with today's 2nd big volume-driven gain. Stubbornly held its ground above its 50 DMA line following an impressive streak of gains when noted with caution in the 3/12/21 mid-day report - "Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017."

4/22/2021 12:59:43 PM - Reported Mar '21 quarterly earnings +47% on +6% sales revenues. Hitting a new 52-week high with today's big volume-driven gain. Stubbornly held its ground above its 50 DMA line following an impressive streak of gains when last noted with caution in the 3/12/21 mid-day report - "Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017."

3/12/2021 11:21:22 AM - Inching to a new 52-week high with today's 6th consecutive gain. Stubbornly held its ground following an impressive streak of gains. Last noted with caution in the 3/01/21 mid-day report - "Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017."

3/1/2021 1:05:07 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/26/2021 12:47:08 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/25/2021 12:48:21 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/24/2021 12:39:36 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/23/2021 1:03:00 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/22/2021 12:56:37 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/17/2021 12:29:42 PM - Perched near its 52-week high today, stubbornly holding its ground following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/12/2021 1:41:00 PM - Perched near its 52-week high today following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/11/2021 1:17:28 PM - Perched near its 52-week high today following an impressive streak of gains. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/10/2021 12:49:40 PM - Perched at its 52-week high with today's 8th consecutive gain. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/9/2021 12:34:05 PM -

Hitting a new 52-week high with today's 7th consecutive gain. Reported earnings +49% on +2% sales revenues for the Dec '20 quarter versus the year ago period. The 3 latest quarterly comparisons have shown strong earnings growth above the +25% minimum guideline (C criteria), but sub par sales revenues growth leaves fundamental concerns. Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

2/4/2020 12:15:39 PM -

Reported earnings +24% on +54% sales revenues for the Dec '19 quarter. Prior quarterly comparisons have not shown strong earnings growth above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

1/10/2020 12:44:57 PM -

Reported earnings +6% on +60% sales revenues for the Sep '19 quarter. Prior quarterly comparisons have not shown strong earnings growth above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

12/18/2019 12:36:58 PM -

12/12/2019 12:43:01 PM -

11/4/2019 12:20:10 PM -

11/1/2019 12:43:20 PM - Reported earnings +6% on +60% sales revenues for the Sep '19 quarter. Prior quarterly comparisons have not shown strong earnings growth above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been strong since its $35 IPO on November 8, 2017.

7/25/2018 12:28:43 PM - Reported earnings +119% on +45% sales revenues for the Jun '18 quarter. Prior quarters also showed very strong sales revenues and earnings growth well above the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history is limited and concerns remain since its $35 IPO on November 8, 2017.